These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 8008271)

  • 21. [LHRH agonists in prostate cancer].
    Rossi D; Cornu JN; Rouprêt M
    Prog Urol; 2007 Apr; 17(2 Suppl 1):287-90. PubMed ID: 17569272
    [No Abstract]   [Full Text] [Related]  

  • 22. Progress in prostate cancer.
    Warde P; Gospodarowicz MK
    CMAJ; 1997 Dec; 157(12):1685-6. PubMed ID: 9418660
    [No Abstract]   [Full Text] [Related]  

  • 23. Management of localized prostate cancer.
    Bissada NK
    J S C Med Assoc; 2000 Feb; 96(2):57-9. PubMed ID: 10710900
    [No Abstract]   [Full Text] [Related]  

  • 24. Management of clinically localized prostate cancer by radical prostatectomy followed by watchful waiting.
    Kirby R
    Nat Clin Pract Urol; 2005 Jun; 2(6):298-303. PubMed ID: 16474812
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pathological staging and biochemical recurrence after neoadjuvant androgen deprivation therapy in combination with radical prostatectomy in clinically localized prostate cancer.
    Hennenfent BR
    Br J Urol; 1998 Jul; 82(1):166. PubMed ID: 9698691
    [No Abstract]   [Full Text] [Related]  

  • 26. Radiation therapy after radical prostatectomy: a review of the issues and options.
    Valicenti RK; Gomella LG; Perez CA
    Semin Radiat Oncol; 2003 Apr; 13(2):130-40. PubMed ID: 12728442
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The prostate specific antigen. Its use as a tumor marker for prostate cancer.
    Kantoff PW; Talcott JA
    Hematol Oncol Clin North Am; 1994 Jun; 8(3):555-72. PubMed ID: 8707772
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A feasibility study of cryotherapy followed by radical prostatectomy for locally advanced prostate cancer.
    Pisters LL; Dinney CP; Pettaway CA; Scott SM; Babaian RJ; von Eschenbach AC; Troncoso P
    J Urol; 1999 Feb; 161(2):509-14. PubMed ID: 9915437
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Editorial comment on: Prospective evaluation of quality of life in prostate cancer patients receiving combined treatment of postoperative radiotherapy plus androgen suppression for PT3 or positive resection margin after radical prostatectomy.
    de Reijke TM
    Eur Urol; 2007 Dec; 52(6):1650-1. PubMed ID: 18074436
    [No Abstract]   [Full Text] [Related]  

  • 30. [Cancer of the prostate: what treatment for what stage?].
    Vanden Bossche M
    Rev Med Brux; 1999 Sep; 20(4):A206-11. PubMed ID: 10523894
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neoadjuvant hormonal deprivation in locally advanced prostate cancer: does it make sense?
    Schulman CC; Wildschutz TP
    Acta Urol Belg; 1996 May; 64(2):57-61. PubMed ID: 8701814
    [No Abstract]   [Full Text] [Related]  

  • 32. [Treatment of localized prostatic cancer--different alternatives. Patients with localized prostatic cancer must actively participate in the choice of therapy].
    Adolfsson J
    Lakartidningen; 2000 Sep; 97(36):3870-4. PubMed ID: 11036336
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Factors influencing men undertaking active surveillance for the management of low-risk prostate cancer.
    Davison BJ; Oliffe JL; Pickles T; Mroz L
    Oncol Nurs Forum; 2009 Jan; 36(1):89-96. PubMed ID: 19136342
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Prostate cancer].
    Tanikawa T
    Rinsho Byori; 2001 Oct; 49(10):955-62. PubMed ID: 11769471
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Diagnosis and treatment of prostate cancer].
    Auvert J
    Ann Urol (Paris); 1999; 33(4):259-62. PubMed ID: 10510707
    [No Abstract]   [Full Text] [Related]  

  • 36. Two different perspectives in the management of pT3 and/or margin-positive prostate cancer after radical prostatectomy.
    Choo R; Kawakami J; Siemens R; Davis BJ; Brundage M; Pisansky TM
    BJU Int; 2006 Oct; 98(4):773-6. PubMed ID: 16978271
    [No Abstract]   [Full Text] [Related]  

  • 37. [Treatment of prostate cancer in patients aged 75 or older].
    Kanamaru H; Akino H; Arai Y; Yoshida H; Okada K
    Gan To Kagaku Ryoho; 1998 Jun; 25(7):985-9. PubMed ID: 9644311
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Advances in prostate cancer treatment.
    Saca-Hazboun H
    ONS Connect; 2008 Sep; 23(9):8-12. PubMed ID: 18807706
    [No Abstract]   [Full Text] [Related]  

  • 39. Effect of neoadjuvant androgen deprivation on circulating prostate cells in the bone marrow of men undergoing radical prostatectomy.
    Wood DP; Beaman A; Banerjee M; Powell I; Pontes E; Cher ML
    Clin Cancer Res; 1998 Sep; 4(9):2119-23. PubMed ID: 9748128
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of BMI on primary treatment of prostate cancer.
    Davies BJ; Walsh TJ; Ross PL; Knight SJ; Sadetsky N; Carroll PR; Kane CJ
    Urology; 2008 Aug; 72(2):406-11. PubMed ID: 18267336
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.